Investigational cream for mild to moderate psoriasis
Part of Skin clinical trials.
This study tests an investigational medication called GM-XANTHO [GM-XAN003] to see if it is safe and effective for people with mild to moderate plaque psoriasis. Participants will use the study drug themselves and must stop other psoriasis treatments during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older.
- You have had plaque psoriasis for at least 6 months.
- Your psoriasis is mild to moderate and stable.
- You are willing to stop other psoriasis treatments (like creams, light therapy, or systemic medications) for the study period.
- You have adequate blood counts and liver/kidney function.
- You are willing to use contraception during the study and for 4 weeks after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new ointment (XJH05) for people with mild-to-moderate plaque psoriasis. It aims to see if this treatment helps reduce symptoms and is safe for topical use.
This trial tests an experimental pill that may help clear psoriasis plaques. It is for people whose current topical treatments (creams or ointments) are not working well enough or cause side effects.
This Phase 1 study tests a new drug (SFA002) in adults with stable plaque psoriasis. It mainly focuses on safety and how the body responds, and may eventually help people with psoriasis plaques.
This trial tests a new medication (HS-10374) taken by mouth to see if it is safe and effective for people with moderate to severe plaque psoriasis. It might help reduce the redness, scaling, and thickness of psoriasis plaques.
This trial tests a new study drug called HSK44459 for people with moderate to severe plaque psoriasis. The hope is that the drug can reduce psoriasis symptoms and improve quality of life. Participation involves receiving the study drug and being monitored for safety and effectiveness.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.